Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report

The use of immune checkpoint inhibitors (ICIs) has drastically transformed the therapeutic landscape in lung cancer. Special focus has been put on immune-related toxicity; however, infections can also seem during ICI treatment. Although rare, tuberculosis (TB) has been increasingly identified after...

Descripción completa

Detalles Bibliográficos
Autores principales: Riudavets, Mariona, Wyplosz, Benjamin, Ghigna, Maria Rosa, Botticella, Angela, Abdayem, Pamela, Pradere, Pauline, Kasraoui, Ines, Roux, Charles, Le Pechoux, Cécile, Garcia, Camilo, Planchard, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052143/
https://www.ncbi.nlm.nih.gov/pubmed/35498384
http://dx.doi.org/10.1016/j.jtocrr.2022.100319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052143/
https://www.ncbi.nlm.nih.gov/pubmed/35498384
http://dx.doi.org/10.1016/j.jtocrr.2022.100319

Ejemplares similares